• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Stem cell injections boost 25 stroke patients' recovery 'by helping nerve cells regrow
Scientists at the University of Texas said they saw an improvement of one point on a six-point scale after six months of testing the therapy on stroke patients within 72 hours of symptoms beginning.
Source: the Mail online | Health - September 17, 2019 Category: Consumer Health News Source Type: news

World-Wide Efficacy of Bone Marrow Derived Mesenchymal Stromal Cells in Preclinical Ischemic Stroke Models: Systematic Review and Meta-Analysis
Conclusions: Our results show worldwide efficacy of BM-MSCs in improving functional outcomes in pre-clinical animal models of stroke and support testing these cells in clinical trials in various ranges of time windows using different delivery routes. The continued growing number of publications showing functional benefit of BM-MSCs are now adding limited value to an oversaturated literature spanning 18 years. Researchers should focus on identifying definitive mechanisms on how BM-MSCs lead to benefit in stroke models. Introduction Ischemic stroke is the 5th leading cause of death and the leading cause of long term di...
Source: Frontiers in Neurology - April 23, 2019 Category: Neurology Source Type: research

First US patient in novel stem cell trial for stroke disability enrolled at UTHealth
(University of Texas Health Science Center at Houston) The first US patient to participate in a global study of a stem cell therapy injected directly into the brain to treat stroke disability was enrolled in the clinical trial this week at The University of Texas Health Science Center at Houston (UTHealth).
Source: EurekAlert! - Medicine and Health - January 25, 2019 Category: International Medicine & Public Health Source Type: news

Neurocognitive deficits in older patients with cancer
ConclusionNeurocognitive deficits (MCI and dementia) are more common in older adults with cancer. Factors associated with neurocognitive deficits include high comorbidity, stroke, warfarin use and metastatic cancer. Identification and management of these conditions is of great relevance in the course of cancer therapy.
Source: Journal of Geriatric Oncology - July 10, 2018 Category: Cancer & Oncology Source Type: research

Stem cell trial for stroke patients suffering chronic motor deficits begins at UTHealth
(University of Texas Health Science Center at Houston) A clinical trial to evaluate the safety and efficacy of a stem cell product injected directly into the brain to treat chronic motor deficits from ischemic stroke has begun at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Source: EurekAlert! - Medicine and Health - May 15, 2017 Category: International Medicine & Public Health Source Type: news

Traumatic Brain Injuries, Stem Cells and Children: A Conversation With Dr. Charles Cox
One of the world's leading experts on cellular therapies for traumatic brain injury (TBI), Dr. Cox directs the Pediatric Surgical Translational Laboratories and Pediatric Program in Regenerative Medicine at the University of Texas Medical School at Houston, as well as the Pediatric Trauma Program at the University of Texas-Houston/Children's Memorial Hermann Hospital in the Texas Medical Center. He is the author of over 120 scientific publications and 20 book chapters and has served on scientific study sections/review groups for the NIH, American Heart Association, Veterans Affairs MERIT Awards, Department of Defense and C...
Source: Healthy Living - The Huffington Post - February 13, 2015 Category: Consumer Health News Source Type: news